Associated Papers
Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer.
Tseng YH et al.
Cell Death Discovery, 2025
39870629 (PubMed )
Supplement: 41420_2025_2300_MOESM2_ESM.xlsx › Supplement_table_2
GEN1 as a risk factor for human congenital anomalies of the kidney and urinary tract.
Du X et al.
Human Genomics, 2024
Select a paper to view details